Real World Evidence Study on Metastatic Prostate Cancer Patient Characteristics, Treatment Patterns and Outcomes in the Pirkanmaa Hospital District in Finland
Latest Information Update: 29 Apr 2024
At a glance
- Drugs Abiraterone (Primary) ; Apalutamide (Primary) ; Cabazitaxel (Primary) ; Degarelix (Primary) ; Docetaxel (Primary) ; Enzalutamide (Primary) ; Goserelin (Primary) ; Leuprorelin (Primary) ; Radium 223 chloride (Primary) ; Triptorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 02 Nov 2023 Status changed from recruiting to completed.
- 16 May 2023 Planned primary completion date changed from 28 Apr 2023 to 30 Nov 2023.
- 17 Apr 2023 Planned number of patients changed from 15000 to 1.